Invention Grant
- Patent Title: Pharmaceutical composition of peptide drug and enzyme-inhibition compounds
- Patent Title (中): 肽药物和酶抑制化合物的药物组合物
-
Application No.: US13374135Application Date: 2011-12-13
-
Publication No.: US08173106B1Publication Date: 2012-05-08
- Inventor: Hsing-Wen Sung , Kiran Sonaje , Hosheng Tu
- Applicant: Hsing-Wen Sung , Kiran Sonaje , Hosheng Tu
- Applicant Address: US CA Newport Beach TW Hsinchu
- Assignee: GP Medical, Inc.,National Tsing Hua University
- Current Assignee: GP Medical, Inc.,National Tsing Hua University
- Current Assignee Address: US CA Newport Beach TW Hsinchu
- Main IPC: A61B5/055
- IPC: A61B5/055
Abstract:
The invention relates to a method of co-administering a peptide or protein drug with an enzyme-resistant PGA-complexone compound orally so to mitigate enzyme attack in the gastrointestinal tract of an animal subject.
Public/Granted literature
- US20120121701A1 PHARMACEUTICAL COMPOSITION OF PEPTIDE DRUG AND ENZYME-INHIBITION COMPOUNDS Public/Granted day:2012-05-17
Information query
